Bhagyanagar India Gets NCLT Nod for Major Restructuring

NCLT Greenlights Major Corporate Overhaul

The National Company Law Tribunal (NCLT), Hyderabad Bench, has approved the Composite Scheme of Arrangement for Bhagyanagar India Limited (BIL), marking a significant step in the company's proposed corporate restructuring. The order, dated January 29, 2026, directs the company to convene meetings of its equity shareholders and its subsidiary's creditors to seek final approval for the plan. This move is aimed at reorganizing the business structure to unlock greater value for stakeholders.

The Two-Pronged Restructuring Strategy

The proposed scheme is built on two key corporate actions: amalgamation and demerger. The first stage involves the amalgamation of Bhagyanagar Copper Private Limited (BCPL), a wholly-owned subsidiary, into its parent company, Bhagyanagar India Limited. This is intended to consolidate operations and streamline the group's structure. The second stage involves the demerger of a specific business undertaking from the consolidated BIL into a new entity named Tieramet Limited. This strategic separation is supported by the differing financial trajectories of BIL and BCPL. While BIL's consolidated profit after tax saw a decline, its subsidiary BCPL demonstrated strong growth in both revenue and profit, reinforcing the rationale to establish the copper segment as a distinct, listed entity.

Shareholder and Creditor Meetings Mandated

As per the NCLT's directive, crucial meetings are scheduled for March 14, 2026, to secure the necessary approvals. The meeting of BCPL's trade creditors will take place at 12:00 PM, followed by the meeting of BIL's equity shareholders at 1:00 PM. Both meetings will be held at Surya Towers in Secunderabad and can be attended via video conferencing or e-voting. To ensure transparency and adherence to procedural norms, the tribunal has appointed key officials. Ms. Siva Praneetha Sreeramula will serve as the Chairperson for the shareholders' meeting, with Mr. Vinay Babu Gade appointed as the Scrutinizer. For the trade creditors' meeting, Ms. G. Sumathi has been appointed as Chairperson.

Share Exchange Ratio and Listing Plans

A key component of the demerger is the value unlocking for existing shareholders. Under the scheme, shareholders of Bhagyanagar India Limited will receive one equity share of ₹2 face value in Tieramet Limited for every one equity share of ₹2 face value they hold in BIL. Following the implementation of the scheme and necessary regulatory approvals, the company plans to list the shares of Tieramet Limited on both the National Stock Exchange (NSE) and the Bombay Stock Exchange (BSE).

Financial Structure of Involved Entities

The restructuring involves three entities with varying capital structures. The amalgamation and demerger will reconfigure the financial landscape of the group. The capital details as of the application date provide a snapshot of the companies involved.

Creditor Obligations and Regulatory Path

The scheme also addresses significant creditor obligations. As of November 30, 2025, BCPL had outstanding dues of ₹297.42 crore to secured creditors, ₹201.86 crore to unsecured creditors, and ₹122.81 crore to 470 trade creditors. The NCLT has dispensed with the need for meetings for several classes of creditors and shareholders across the companies, streamlining the approval process. The journey to this stage began with the company receiving 'no adverse observation' letters from both BSE and NSE in December 2025, which was a prerequisite for filing the scheme with the NCLT. The company is now required to issue notices for the upcoming meetings in designated newspapers to ensure all stakeholders are informed.

Conclusion and Next Steps

The NCLT's order is a pivotal approval that sets the stage for the final phase of Bhagyanagar India's restructuring. The focus now shifts to the shareholder and creditor meetings on March 14, 2026. The outcome of these meetings will determine the implementation of the amalgamation and the demerger of the business into Tieramet Limited, potentially creating a new, separately listed entity and reshaping the future of the group.